Peptide Synthesis Market Size, Share, Industry Trends and Forecast to 2030

Market Size & CAGR of Peptide Synthesis Market in 2021

The global peptide synthesis market is expected to show a steady growth rate with a Compound Annual Growth Rate (CAGR) of 5.8% from 2021 to 2026. In 2021, the market size was estimated to be USD 308.5 million, and it is projected to reach USD 453.7 million by the end of 2026. This growth can be attributed to the increasing demand for peptides in various industries such as healthcare, pharmaceuticals, and biotechnology.

COVID-19 Impact on the Peptide Synthesis Market

The COVID-19 pandemic has had a significant impact on the peptide synthesis market. Due to the outbreak of the virus, there has been a disruption in the global supply chain, leading to delays in the production and distribution of peptides. Many research and development activities related to peptides have also been put on hold, impacting the market growth. However, the increasing focus on healthcare and the development of peptide-based therapeutics to combat the virus have created new opportunities for market players.

Peptide Synthesis Dynamics

Peptide synthesis is the process of creating peptides by linking amino acids together in a specific sequence. These peptides have various applications in pharmaceuticals, biotechnology, and research. The market for peptide synthesis is driven by the increasing demand for peptide-based drugs and therapeutics, as they offer targeted and specific treatments for various diseases. The advancements in peptide synthesis technologies, such as solid-phase peptide synthesis and liquid-phase peptide synthesis, have also contributed to the growth of the market.

Segments and Related Analysis

The peptide synthesis market can be segmented based on product type, technology, application, and end-user. By product type, the market is divided into reagents, equipment, and services. Based on technology, the market is categorized into solid-phase peptide synthesis, liquid-phase peptide synthesis, and hybrid peptide synthesis. In terms of application, the market is segmented into therapeutics, diagnostics, and research. The end-users of peptide synthesis include pharmaceutical & biotechnology companies, contract research organizations, and academic & research institutes.

By Region Analysis

The global peptide synthesis market is geographically segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the market due to the presence of key market players, technological advancements, and high healthcare expenditure. Europe follows closely, with a significant share in the market attributed to the rising demand for peptide-based therapeutics. The Asia Pacific region is expected to grow at a rapid pace due to the increasing investments in research and development activities in countries like China and India.

Key Market Players and Competitive Landscape

Some of the key players in the peptide synthesis market include GenScript Biotech Corporation, Thermo Fisher Scientific Inc., Bio-Synthesis Inc., CEM Corporation, and AAPPTec LLC. These companies focus on product innovations, collaborations, and strategic partnerships to gain a competitive edge in the market. The competitive landscape of the market is characterized by intense competition, with companies striving to expand their product portfolios and strengthen their market presence.

Recent Happenings in the Peptide Synthesis Market

In recent years, the peptide synthesis market has witnessed several developments aimed at enhancing the efficiency and effectiveness of peptide synthesis processes. Companies have invested in research and development activities to introduce new technologies and products in the market. For instance, GenScript Biotech Corporation launched a new automated peptide synthesizer, which offers high-throughput synthesis capabilities. Such advancements are expected to drive the growth of the market and open up new opportunities for market players.